PAMU
TXMD icon

Pictet Asset Management (UK)’s TherapeuticsMD TXMD Stock Holding History

Pictet Asset Management (UK)’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$14K Hold
236
– – ﹤0.01% 1750
2021
Q1 		$16K Sell
236
-494
-68% -$38.7K ﹤0.01% 1787
2020
Q4 		$44K Buy
730
+524
+254% +$35.8K ﹤0.01% 1738
2020
Q3 		$16K Hold
206
– – ﹤0.01% 1558
2020
Q2 		$13K Hold
206
– – ﹤0.01% 1145
2020
Q1 		$11K Buy
+206
New +$20.4K ﹤0.01% 1115

Other funds holding TXMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Pictet Asset Management (UK)'s TXMD Position: Q2 2021 in Review

Pictet Asset Management (UK) held its TherapeuticsMD (TXMD) position steady in Q2 2021 at 236 shares worth $14K. The position accounts for ﹤0.01% of the portfolio, ranked #1750.

Pictet Asset Management (UK) first reported a position in TXMD in Q1 2020 and has held it in 6 quarters since. The position peaked at $44K in Q4 2020. 154 funds tracked by Wall St. Rank hold TXMD as of Q2 2021.

  • Pictet Asset Management (UK) held 236 shares of TherapeuticsMD worth $14K as of Q2 2021.
  • Pictet Asset Management (UK) left its TherapeuticsMD share count unchanged in Q2 2021.
  • TherapeuticsMD made up ﹤0.01% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #1750 holding.
  • Pictet Asset Management (UK) first reported a position in TherapeuticsMD in Q1 2020 and has held it in 6 quarters since.
  • Pictet Asset Management (UK)'s TherapeuticsMD position peaked at $44K in Q4 2020.
  • 154 funds tracked by Wall St. Rank held TherapeuticsMD as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.